ZURICH (Reuters) - Actelion has submitted heart and lung drug macitentan to European health regulators, the second major step for the drug the Swiss group is positioning as a viable successor to its current top seller.
3d anatomy human body free visible body 3d human anatomy
No comments:
Post a Comment